vs
Side-by-side financial comparison of SAUL CENTERS, INC. (BFS) and NATURES SUNSHINE PRODUCTS INC (NATR). Click either name above to swap in a different company.
NATURES SUNSHINE PRODUCTS INC is the larger business by last-quarter revenue ($123.8M vs $75.1M, roughly 1.6× SAUL CENTERS, INC.). SAUL CENTERS, INC. runs the higher net margin — 8.7% vs 3.3%, a 5.3% gap on every dollar of revenue. On growth, SAUL CENTERS, INC. posted the faster year-over-year revenue change (10.6% vs 4.7%). Over the past eight quarters, SAUL CENTERS, INC.'s revenue compounded faster (6.2% CAGR vs 5.6%).
Saul Centers, Inc. is a self-administered real estate investment trust (REIT) headquartered in the United States. It primarily owns, operates, and develops high-quality shopping centers, mixed-use properties, and multifamily residential assets, with its core portfolio concentrated in the Washington D.C. metropolitan area and other select high-growth U.S. regional markets.
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
BFS vs NATR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $75.1M | $123.8M |
| Net Profit | $6.5M | $4.1M |
| Gross Margin | — | 72.5% |
| Operating Margin | 65.4% | 4.3% |
| Net Margin | 8.7% | 3.3% |
| Revenue YoY | 10.6% | 4.7% |
| Net Profit YoY | -19.6% | 1379.4% |
| EPS (diluted) | $0.15 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.1M | $123.8M | ||
| Q3 25 | $72.0M | $128.3M | ||
| Q2 25 | $70.8M | $114.8M | ||
| Q1 25 | $71.9M | $113.2M | ||
| Q4 24 | $67.9M | $118.2M | ||
| Q3 24 | $67.3M | $114.6M | ||
| Q2 24 | $66.9M | $110.6M | ||
| Q1 24 | $66.7M | $111.0M |
| Q4 25 | $6.5M | $4.1M | ||
| Q3 25 | $10.5M | $5.3M | ||
| Q2 25 | $10.7M | $5.3M | ||
| Q1 25 | $9.8M | $4.7M | ||
| Q4 24 | $8.1M | $-321.0K | ||
| Q3 24 | $14.5M | $4.3M | ||
| Q2 24 | $14.4M | $1.3M | ||
| Q1 24 | $13.6M | $2.3M |
| Q4 25 | — | 72.5% | ||
| Q3 25 | — | 73.3% | ||
| Q2 25 | — | 71.7% | ||
| Q1 25 | — | 72.1% | ||
| Q4 24 | — | 72.0% | ||
| Q3 24 | 73.6% | 71.3% | ||
| Q2 24 | 74.2% | 71.4% | ||
| Q1 24 | 72.8% | 71.2% |
| Q4 25 | 65.4% | 4.3% | ||
| Q3 25 | 69.1% | 7.0% | ||
| Q2 25 | 68.7% | 3.7% | ||
| Q1 25 | 66.5% | 5.4% | ||
| Q4 24 | 82.9% | 3.8% | ||
| Q3 24 | 72.8% | 4.6% | ||
| Q2 24 | 75.0% | 5.1% | ||
| Q1 24 | 72.4% | 4.2% |
| Q4 25 | 8.7% | 3.3% | ||
| Q3 25 | 14.6% | 4.2% | ||
| Q2 25 | 15.1% | 4.6% | ||
| Q1 25 | 13.6% | 4.2% | ||
| Q4 24 | 11.9% | -0.3% | ||
| Q3 24 | 21.5% | 3.8% | ||
| Q2 24 | 21.6% | 1.2% | ||
| Q1 24 | 20.4% | 2.1% |
| Q4 25 | $0.15 | $0.23 | ||
| Q3 25 | $0.32 | $0.30 | ||
| Q2 25 | $0.33 | $0.28 | ||
| Q1 25 | $0.29 | $0.25 | ||
| Q4 24 | $0.22 | $-0.02 | ||
| Q3 24 | $0.48 | $0.23 | ||
| Q2 24 | $0.48 | $0.07 | ||
| Q1 24 | $0.45 | $0.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.7M | $93.9M |
| Total DebtLower is stronger | $468.4M | — |
| Stockholders' EquityBook value | $307.8M | $161.6M |
| Total Assets | $2.2B | $261.1M |
| Debt / EquityLower = less leverage | 1.52× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.7M | $93.9M | ||
| Q3 25 | $11.8M | $95.6M | ||
| Q2 25 | $5.3M | $81.3M | ||
| Q1 25 | $6.5M | $86.5M | ||
| Q4 24 | $10.3M | $84.7M | ||
| Q3 24 | $7.2M | $78.7M | ||
| Q2 24 | $6.9M | $68.7M | ||
| Q1 24 | $7.1M | $77.8M |
| Q4 25 | $468.4M | — | ||
| Q3 25 | $1.6B | — | ||
| Q2 25 | $1.6B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $455.8M | — | ||
| Q3 24 | $1.5B | — | ||
| Q2 24 | $1.4B | — | ||
| Q1 24 | $1.4B | $2.1M |
| Q4 25 | $307.8M | $161.6M | ||
| Q3 25 | $316.6M | $166.7M | ||
| Q2 25 | $322.4M | $163.7M | ||
| Q1 25 | $328.4M | $167.1M | ||
| Q4 24 | $335.8M | $161.0M | ||
| Q3 24 | $341.8M | $162.6M | ||
| Q2 24 | $345.7M | $156.4M | ||
| Q1 24 | $347.1M | $159.7M |
| Q4 25 | $2.2B | $261.1M | ||
| Q3 25 | $2.2B | $264.8M | ||
| Q2 25 | $2.1B | $254.9M | ||
| Q1 25 | $2.1B | $252.7M | ||
| Q4 24 | $2.1B | $240.9M | ||
| Q3 24 | $2.1B | $245.3M | ||
| Q2 24 | $2.1B | $235.8M | ||
| Q1 24 | $2.0B | $247.3M |
| Q4 25 | 1.52× | — | ||
| Q3 25 | 5.02× | — | ||
| Q2 25 | 4.85× | — | ||
| Q1 25 | 4.70× | — | ||
| Q4 24 | 1.36× | — | ||
| Q3 24 | 4.37× | — | ||
| Q2 24 | 4.17× | — | ||
| Q1 24 | 4.06× | 0.01× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $99.8M | $9.9M |
| Free Cash FlowOCF − Capex | — | $7.6M |
| FCF MarginFCF / Revenue | — | 6.1% |
| Capex IntensityCapex / Revenue | — | 1.9% |
| Cash ConversionOCF / Net Profit | 15.35× | 2.41× |
| TTM Free Cash FlowTrailing 4 quarters | — | $28.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $99.8M | $9.9M | ||
| Q3 25 | $20.6M | $18.5M | ||
| Q2 25 | $26.6M | $4.3M | ||
| Q1 25 | $30.4M | $2.6M | ||
| Q4 24 | $121.2M | $12.2M | ||
| Q3 24 | $26.5M | $9.6M | ||
| Q2 24 | $32.1M | $1.3M | ||
| Q1 24 | $33.8M | $2.2M |
| Q4 25 | — | $7.6M | ||
| Q3 25 | — | $16.8M | ||
| Q2 25 | — | $3.0M | ||
| Q1 25 | — | $1.5M | ||
| Q4 24 | — | $10.0M | ||
| Q3 24 | $-28.3M | $7.9M | ||
| Q2 24 | $-12.5M | $-2.0M | ||
| Q1 24 | $-11.7M | $-1.5M |
| Q4 25 | — | 6.1% | ||
| Q3 25 | — | 13.1% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 1.3% | ||
| Q4 24 | — | 8.5% | ||
| Q3 24 | -42.1% | 6.9% | ||
| Q2 24 | -18.7% | -1.9% | ||
| Q1 24 | -17.6% | -1.4% |
| Q4 25 | — | 1.9% | ||
| Q3 25 | — | 1.3% | ||
| Q2 25 | — | 1.2% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | 81.5% | 1.5% | ||
| Q2 24 | 66.7% | 3.0% | ||
| Q1 24 | 68.3% | 3.3% |
| Q4 25 | 15.35× | 2.41× | ||
| Q3 25 | 1.97× | 3.46× | ||
| Q2 25 | 2.48× | 0.81× | ||
| Q1 25 | 3.10× | 0.55× | ||
| Q4 24 | 14.98× | — | ||
| Q3 24 | 1.83× | 2.21× | ||
| Q2 24 | 2.22× | 0.97× | ||
| Q1 24 | 2.48× | 0.94× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BFS
Segment breakdown not available.
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
